Cognitive Rehabilitation and Exposure Therapy for Hoarding Disorder
(CREST Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial requires that participants have been stable on their medications for at least 8 weeks, so you should not need to stop taking your current medications unless you are using benzodiazepines, which are not allowed.
What data supports the effectiveness of the treatment Cognitive Rehabilitation and Exposure/Sorting Therapy (CREST) for Hoarding Disorder?
Research shows that Cognitive Rehabilitation and Exposure/Sorting Therapy (CREST) is effective in reducing hoarding symptoms in older adults, with improvements in executive functioning (mental skills used in managing tasks) and reductions in anxiety and depression. Studies also indicate that CREST leads to significant decreases in hoarding severity compared to other treatments.12345
Is Cognitive Rehabilitation and Exposure Therapy safe for humans?
How is the treatment CREST different from other treatments for hoarding disorder?
CREST is unique because it combines cognitive rehabilitation, which helps improve thinking skills, with exposure and sorting therapy, which involves gradually facing and organizing clutter. This approach not only reduces hoarding symptoms but also improves executive functioning (mental skills like planning and problem-solving) in older adults, making it more effective than traditional cognitive-behavioral therapy alone.12347
What is the purpose of this trial?
Hoarding disorder (HD) is a chronic, progressive, and debilitating psychiatric condition that leads to devastating personal and public consequences, particularly for older adults. This confirmatory efficacy trial will advance our knowledge of the mechanisms of action in the treatment of HD as well as reduce symptom severity, disability, and community consequences.
Research Team
Catherine Ayers, PhD
Principal Investigator
University of California, San Diego
Eligibility Criteria
This trial is for adults aged 50 or older who have been diagnosed with Hoarding Disorder (HD) as their primary condition and are stable on medications. They must understand and agree to participate voluntarily. People with current psychosis, substance use disorders, benzodiazepine use, suicidality, neurodegenerative diseases, or those already in exposure therapy cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Cognitive Rehabilitation and Exposure/Sorting Therapy (CREST) with 26 weekly sessions over 32 weeks
Mid-treatment Evaluation
Evaluation of treatment outcome, including hoarding severity and functional outcomes
End of Treatment Evaluation
Final evaluation of treatment outcome, including hoarding severity and functional outcomes
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Case Management
- Cognitive Rehabilitation and Exposure/Sorting Therapy (CREST)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor